Clinical trial OASIS II
| Kankers | |
|---|---|
| Organ | Lymfoom |
| Trial status | Trial gesloten voor rekrutering |
| Trial type |
Interventioneel met experimenteel geneesmiddel
|
| Fase | Fase van de proef 2 |
| Academisch proef | Ja |
| Sponsor | Lysarc |
| EudraCT Identifier | 2020-004910-37 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04802590 |
| Laatste update |